Europe Protease Inhibitor Market Research Report Forecast 2017 to 2022

November 2017 | 126 pages | ID: E6C77809B32EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Protease Inhibitor Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Protease Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Protease Inhibitor market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Protease Inhibitor Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
CSL Ltd. (Australia)
Grifols S.A (Spain)
Baxalta Incorporated (U.S.)
Octapharma AG (Switzerland)
Kedrion S.p.A (Italy)
China Biologic Products, Inc. (China)
Biotest AG (Germany)
LFB S.A (France)
Bio Product Laboratory Ltd. (U.K.)

Europe Protease Inhibitor Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Protease Inhibitor Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 PROTEASE INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of Protease Inhibitor
1.2 Classification of Protease Inhibitor
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Protease Inhibitor
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Protease Inhibitor Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Protease Inhibitor (2012-2022)
  1.5.1 Europe Protease Inhibitor Sales and Growth Rate (2012-2022)
  1.5.2 Europe Protease Inhibitor Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON PROTEASE INHIBITOR INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 PROTEASE INHIBITOR MANUFACTURING COST ANALYSIS

3.1 Protease Inhibitor Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Protease Inhibitor

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Protease Inhibitor Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Protease Inhibitor Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE PROTEASE INHIBITOR MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Protease Inhibitor Market Competition by Manufacturers
  5.1.1 Europe Protease Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Protease Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Protease Inhibitor (Volume and Value) by Type
  5.2.1 Europe Protease Inhibitor Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Protease Inhibitor Revenue and Market Share by Type (2012-2017)
5.3 Europe Protease Inhibitor (Volume and Value) by Countries
  5.3.1 Europe Protease Inhibitor Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Protease Inhibitor Revenue and Market Share by Countries (2012-2017)
5.4 Europe Protease Inhibitor (Volume) by Application

6 GERMANY PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Protease Inhibitor Sales and Value (2012-2017)
  6.1.1 Germany Protease Inhibitor Sales and Growth Rate (2012-2017)
  6.1.2 Germany Protease Inhibitor Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Protease Inhibitor Sales Price Trend (2012-2017)
6.2 Germany Protease Inhibitor Sales and Market Share by Manufacturers
6.3 Germany Protease Inhibitor Sales and Market Share by Type
6.4 Germany Protease Inhibitor Sales and Market Share by Application

7 FRANCE PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

7.1 France Protease Inhibitor Sales and Value (2012-2017)
  7.1.1 France Protease Inhibitor Sales and Growth Rate (2012-2017)
  7.1.2 France Protease Inhibitor Revenue and Growth Rate (2012-2017)
  7.1.3 France Protease Inhibitor Sales Price Trend (2012-2017)
7.2 France Protease Inhibitor Sales and Market Share by Manufacturers
7.3 France Protease Inhibitor Sales and Market Share by Type
7.4 France Protease Inhibitor Sales and Market Share by Application

8 UK PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

8.1 UK Protease Inhibitor Sales and Value (2012-2017)
  8.1.1 UK Protease Inhibitor Sales and Growth Rate (2012-2017)
  8.1.2 UK Protease Inhibitor Revenue and Growth Rate (2012-2017)
  8.1.3 UK Protease Inhibitor Sales Price Trend (2012-2017)
8.2 UK Protease Inhibitor Sales and Market Share by Manufacturers
8.3 UK Protease Inhibitor Sales and Market Share by Type
8.4 UK Protease Inhibitor Sales and Market Share by Application

9 RUSSIA PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Protease Inhibitor Sales and Value (2012-2017)
  9.1.1 Russia Protease Inhibitor Sales and Growth Rate (2012-2017)
  9.1.2 Russia Protease Inhibitor Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Protease Inhibitor Sales Price Trend (2012-2017)
9.2 Russia Protease Inhibitor Sales and Market Share by Manufacturers
9.3 Russia Protease Inhibitor Sales and Market Share by Type
9.4 Russia Protease Inhibitor Sales and Market Share by Application

10 ITALY PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Protease Inhibitor Sales and Value (2012-2017)
  10.1.1 Italy Protease Inhibitor Sales and Growth Rate (2012-2017)
  10.1.2 Italy Protease Inhibitor Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Protease Inhibitor Sales Price Trend (2012-2017)
10.2 Italy Protease Inhibitor Sales and Market Share by Manufacturers
10.3 Italy Protease Inhibitor Sales and Market Share by Type
10.4 Italy Protease Inhibitor Sales and Market Share by Application

11 SPAIN PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Protease Inhibitor Sales and Value (2012-2017)
  11.1.1 Spain Protease Inhibitor Sales and Growth Rate (2012-2017)
  11.1.2 Spain Protease Inhibitor Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Protease Inhibitor Sales Price Trend (2012-2017)
11.2 Spain Protease Inhibitor Sales and Market Share by Manufacturers
11.3 Spain Protease Inhibitor Sales and Market Share by Type
11.4 Spain Protease Inhibitor Sales and Market Share by Application

12 BENELUX PROTEASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Protease Inhibitor Sales and Value (2012-2017)
  12.1.1 Benelux Protease Inhibitor Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Protease Inhibitor Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Protease Inhibitor Sales Price Trend (2012-2017)
12.2 Benelux Protease Inhibitor Sales and Market Share by Manufacturers
12.3 Benelux Protease Inhibitor Sales and Market Share by Type
12.4 Benelux Protease Inhibitor Sales and Market Share by Application

13 EUROPE PROTEASE INHIBITOR MANUFACTURERS ANALYSIS

13.1 CSL Ltd. (Australia)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Grifols S.A (Spain)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Baxalta Incorporated (U.S.)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Octapharma AG (Switzerland)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Kedrion S.p.A (Italy)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 China Biologic Products, Inc. (China)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Biotest AG (Germany)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 LFB S.A (France)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Bio Product Laboratory Ltd. (U.K.)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE PROTEASE INHIBITOR MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Protease Inhibitor Market Forecast by Type (2017-2022)
15.9 Europe Protease Inhibitor Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Protease Inhibitor
Table Classification of Protease Inhibitor
Figure Europe Sales Market Share of Protease Inhibitor by Type in 2016
Table Application of Protease Inhibitor
Figure Europe Sales Market Share of Protease Inhibitor by Application in 2016
Figure Germany Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure France Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure UK Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure Russia Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure Italy Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure Spain Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure Benelux Protease Inhibitor Revenue and Growth Rate (2012-2022)
Figure Europe Protease Inhibitor Sales and Growth Rate (2012-2022)
Figure Europe Protease Inhibitor Revenue and Growth Rate (2012-2022)
Table Europe Protease Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table Europe Protease Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Protease Inhibitor Sales Share by Manufacturers
Figure 2016 Protease Inhibitor Sales Share by Manufacturers
Table Europe Protease Inhibitor Revenue by Manufacturers (2015 and 2016)
Table Europe Protease Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Protease Inhibitor Revenue Share by Manufacturers
Table 2016 Europe Protease Inhibitor Revenue Share by Manufacturers
Table Europe Protease Inhibitor Sales and Market Share by Type (2012-2017)
Table Europe Protease Inhibitor Sales Share by Type (2012-2017)
Figure Sales Market Share of Protease Inhibitor by Type (2012-2017)
Figure Europe Protease Inhibitor Sales Growth Rate by Type (2012-2017)
Table Europe Protease Inhibitor Revenue and Market Share by Type (2012-2017)
Table Europe Protease Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Protease Inhibitor by Type (2012-2017)
Figure Europe Protease Inhibitor Revenue Growth Rate by Type (2012-2017)
Table Europe Protease Inhibitor Sales and Market Share by Countries (2012-2017)
Table Europe Protease Inhibitor Sales Share by Countries (2012-2017)
Figure Sales Market Share of Protease Inhibitor by Countries (2012-2017)
Table Europe Protease Inhibitor Revenue and Market Share by Countries (2012-2017)
Table Europe Protease Inhibitor Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Protease Inhibitor by Countries (2012-2017)
Table Europe Protease Inhibitor Sales and Market Share by Application (2012-2017)
Table Europe Protease Inhibitor Sales Share by Application (2012-2017)
Figure Sales Market Share of Protease Inhibitor by Application (2012-2017)
Figure Germany Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure Germany Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure Germany Protease Inhibitor Sales Price Trend (2012-2017)
Table Germany Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table Germany Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Germany Protease Inhibitor Sales by Type (2015 and 2016)
Table Germany Protease Inhibitor Market Share by Type (2015 and 2016)
Table Germany Protease Inhibitor Sales by Application (2015 and 2016)
Table Germany Protease Inhibitor Market Share by Application (2015 and 2016)
Figure France Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure France Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure France Protease Inhibitor Sales Price Trend (2012-2017)
Table France Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table France Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table France Protease Inhibitor Sales by Type (2015 and 2016)
Table France Protease Inhibitor Market Share by Type (2015 and 2016)
Table France Protease Inhibitor Sales by Application (2015 and 2016)
Table France Protease Inhibitor Market Share by Application (2015 and 2016)
Figure UK Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure UK Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure UK Protease Inhibitor Sales Price Trend (2012-2017)
Table UK Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table UK Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table UK Protease Inhibitor Sales by Type (2015 and 2016)
Table UK Protease Inhibitor Market Share by Type (2015 and 2016)
Table UK Protease Inhibitor Sales by Application (2015 and 2016)
Table UK Protease Inhibitor Market Share by Application (2015 and 2016)
Figure Russia Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure Russia Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure Russia Protease Inhibitor Sales Price Trend (2012-2017)
Table Russia Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table Russia Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Russia Protease Inhibitor Sales by Type (2015 and 2016)
Table Russia Protease Inhibitor Market Share by Type (2015 and 2016)
Table Russia Protease Inhibitor Sales by Application (2015 and 2016)
Table Russia Protease Inhibitor Market Share by Application (2015 and 2016)
Figure Italy Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure Italy Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure Italy Protease Inhibitor Sales Price Trend (2012-2017)
Table Italy Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table Italy Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Italy Protease Inhibitor Sales by Type (2015 and 2016)
Table Italy Protease Inhibitor Market Share by Type (2015 and 2016)
Table Italy Protease Inhibitor Sales by Application (2015 and 2016)
Table Italy Protease Inhibitor Market Share by Application (2015 and 2016)
Figure Spain Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure Spain Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure Spain Protease Inhibitor Sales Price Trend (2012-2017)
Table Spain Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table Spain Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Spain Protease Inhibitor Sales by Type (2015 and 2016)
Table Spain Protease Inhibitor Market Share by Type (2015 and 2016)
Table Spain Protease Inhibitor Sales by Application (2015 and 2016)
Table Spain Protease Inhibitor Market Share by Application (2015 and 2016)
Figure Benelux Protease Inhibitor Sales and Growth Rate (2012-2017)
Figure Benelux Protease Inhibitor Revenue and Growth Rate (2012-2017)
Figure Benelux Protease Inhibitor Sales Price Trend (2012-2017)
Table Benelux Protease Inhibitor Sales by Manufacturers (2015 and 2016)
Table Benelux Protease Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Benelux Protease Inhibitor Sales by Type (2015 and 2016)
Table Benelux Protease Inhibitor Market Share by Type (2015 and 2016)
Table Benelux Protease Inhibitor Sales by Application (2015 and 2016)
Table Benelux Protease Inhibitor Market Share by Application (2015 and 2016)
Table CSL Ltd. (Australia) Basic Information List
Table CSL Ltd. (Australia) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Ltd. (Australia) Protease Inhibitor Sales Market Share (2012-2017)
Table Grifols S.A (Spain) Basic Information List
Table Grifols S.A (Spain) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Grifols S.A (Spain) Protease Inhibitor Sales Market Share (2012-2017)
Table Baxalta Incorporated (U.S.) Basic Information List
Table Baxalta Incorporated (U.S.) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Baxalta Incorporated (U.S.) Protease Inhibitor Sales Market Share (2012-2017)
Table Octapharma AG (Switzerland) Basic Information List
Table Octapharma AG (Switzerland) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Octapharma AG (Switzerland) Protease Inhibitor Sales Market Share (2012-2017)
Table Kedrion S.p.A (Italy) Basic Information List
Table Kedrion S.p.A (Italy) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kedrion S.p.A (Italy) Protease Inhibitor Sales Market Share (2012-2017)
Table China Biologic Products, Inc. (China) Basic Information List
Table China Biologic Products, Inc. (China) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table China Biologic Products, Inc. (China) Protease Inhibitor Sales Market Share (2012-2017)
Table Biotest AG (Germany) Basic Information List
Table Biotest AG (Germany) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotest AG (Germany) Protease Inhibitor Sales Market Share (2012-2017)
Table LFB S.A (France) Basic Information List
Table LFB S.A (France) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table LFB S.A (France) Protease Inhibitor Sales Market Share (2012-2017)
Table Bio Product Laboratory Ltd. (U.K.) Basic Information List
Table Bio Product Laboratory Ltd. (U.K.) Protease Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bio Product Laboratory Ltd. (U.K.) Protease Inhibitor Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Protease Inhibitor
Figure Manufacturing Process Analysis of Protease Inhibitor
Figure Protease Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Protease Inhibitor Major Manufacturers in 2016
Table Major Buyers of Protease Inhibitor
Table Distributors/Traders List
Figure Germany Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Germany Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure France Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure France Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure UK Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure UK Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Russia Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Italy Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Spain Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Protease Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Protease Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table Europe Protease Inhibitor Sales Forecast by Type (2017-2022)
Table Europe Protease Inhibitor Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

CSL Ltd. (Australia)
Grifols S.A (Spain)
Baxalta Incorporated (U.S.)
Octapharma AG (Switzerland)
Kedrion S.p.A (Italy)
China Biologic Products, Inc. (China)
Biotest AG (Germany)
LFB S.A (France)
Bio Product Laboratory Ltd. (U.K.)
Sanquin (Netherlands)